NATERA INC (NTRA) Stock Price, Quote, News and Overview
NASDAQ:NTRA - Nasdaq - US6323071042 - Common Stock - Currency: USD
NTRA Quote, Performance and Key Statistics
NATERA INC
NASDAQ:NTRA (1/24/2025, 4:43:39 PM)
After market: 167.61 0 (0%)167.61
-4.21 (-2.45%)
The current stock price of NTRA is 167.61 USD. In the past month the price increased by 3.47%. In the past year, price increased by 156.13%.
NTRA Latest News, Press Releases and Analysis
Why the high growth investor may take a look at NATERA INC (NASDAQ:NTRA).
Exploring high growth characteristics of NATERA INC (NASDAQ:NTRA). A fundamental and technical analysis of (NASDAQ:NTRA).
Natera to Present New Data at the 2025 ASCO GI Symposium
Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone
The company is working to expand the uses and reimbursement for its blood-based tests for cancer.
Moderna, GameStop And Snap Are Among Top Large-Cap Losers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?
Eleven large-cap stocks were the worst performers in the last week. Short positions announced for FTAI, revenue updates for MRNA, and price forecasts changed for GME, SNAP, RKLB, NTRA, LLY, ICLR, BNTX, NVO, and BMRN.
NTRA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 15.84 | 300.94B | ||
| AMGN | AMGEN INC | 14.33 | 148.05B | ||
| GILD | GILEAD SCIENCES INC | 21.01 | 115.99B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 862 | 113.22B | ||
| REGN | REGENERON PHARMACEUTICALS | 14.88 | 74.26B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.80B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 35.95B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.47B | ||
| ONC | BEIGENE LTD-ADR | N/A | 23.64B | ||
| BIIB | BIOGEN INC | 8.95 | 21.30B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 17.52B | ||
| UTHR | UNITED THERAPEUTICS CORP | 16.29 | 16.55B |
Related stock screener links
About NTRA
Company Profile
Natera, Inc. is a diagnostics company, which engages in the discovery, development, and commercialization of genetic testing services. The company is headquartered in Austin, Texas and currently employs 3,282 full-time employees. The company went IPO on 2015-07-02. Its cell-free deoxyribonucleic acid (cfDNA) technology combines its molecular assays, which reliably measure many informative regions across the genome from samples as small as a single cell. The firm's product offerings include Panorama Non-Invasive Prenatal Test (NIPT), Vistara, Horizon Carrier Screening, Spectrum Preimplantation Genetics, Anora Miscarriage Test, Empower, and Prospera. The firm also offers Constellation, a cloud-based software platform that enables laboratory customers to gain access through the cloud to the Company’s algorithms and bioinformatics in order to validate and launch tests based on the Company’s technology. Its NIPT screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother.
Company Info
NATERA INC
13011 Mccallen Pass, Building A Suite 100
Austin TEXAS 78753 US
CEO: Steve Chapman
Employees: 3288
Company Website: https://www.natera.com/
Investor Relations: https://investor.natera.com
Phone: 16502499090
NTRA FAQ
What is the stock price of NTRA?
The current stock price of NTRA is 167.61 USD.
What is the symbol for NATERA INC stock?
The exchange symbol of NATERA INC is NTRA and it is listed on the Nasdaq exchange.
On which exchange is NTRA stock listed?
NTRA stock is listed on the Nasdaq exchange.
Is NTRA a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for NTRA, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of NTRA.
Does NTRA stock pay dividends?
NTRA does not pay a dividend.
What is the Price/Earnings (PE) ratio of NTRA?
NTRA does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.76).
What is the Short Interest ratio of NTRA stock?
The outstanding short interest for NTRA is 3.41% of its float.
NTRA Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to NTRA. When comparing the yearly performance of all stocks, NTRA is one of the better performing stocks in the market, outperforming 96.47% of all stocks.
NTRA Fundamental Analysis
ChartMill assigns a fundamental rating of 4 / 10 to NTRA. While NTRA seems to be doing ok healthwise, there are quite some concerns on its profitability.
NTRA Financial Highlights
Over the last trailing twelve months NTRA reported a non-GAAP Earnings per Share(EPS) of -1.76. The EPS increased by 61.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -13.49% | ||
| ROE | -24.44% | ||
| Debt/Equity | 0.42 |
NTRA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to NTRA. The Buy consensus is the average rating of analysts ratings from 25 analysts.
For the next year, analysts expect an EPS growth of 56.6% and a revenue growth 55.01% for NTRA